Brancale Andrea, Silvestri Romano
Welsh School of Pharmacy, Cardiff University, King Edward VII Avenue, Cardiff, CF10 3XF, United Kingdom.
Med Res Rev. 2007 Mar;27(2):209-38. doi: 10.1002/med.20080.
Microtubules are the basic components of cell structure, which take part in a wide number of pivotal cellular functions. Drugs that are able to modulate the microtubule assembly either by inhibition of tubulin polymerization or by blocking microtubule disassembly are of great interest in anti-cancer therapy. Several tubulin polymerization inhibitors characterized by the presence of an indole nucleus have been obtained from natural sources or have been prepared by semi-synthesis. In the last decade an ever increasing number of synthetic indoles have been reported. We have reviewed anti-tubulin agents obtained by synthesis having an indole as core nucleus. The synthesis, the biological activity, and the structure - activity relationship aspects of 3-formyl-2-phenylindoles, heterocombretastatins, diarylindoles, 2-aroylindoles, D-24851, 2-aryl-3-aroylindoles, 3-aroyl- and 1-aroylindoles, and arylthioindoles are discussed.
微管是细胞结构的基本组成部分,参与多种关键的细胞功能。能够通过抑制微管蛋白聚合或阻断微管解聚来调节微管组装的药物在抗癌治疗中备受关注。几种以吲哚核为特征的微管蛋白聚合抑制剂已从天然来源获得或通过半合成制备。在过去十年中,报道的合成吲哚数量不断增加。我们综述了以吲哚为核心核通过合成得到的抗微管蛋白药物。讨论了3-甲酰基-2-苯基吲哚、杂合康普他汀、二芳基吲哚、2-芳酰基吲哚、D-24851、2-芳基-3-芳酰基吲哚、3-芳酰基-和1-芳酰基吲哚以及芳基硫代吲哚的合成、生物活性和构效关系方面。